Biotech Showcase™ 2017: J&J poised to establish no-strings-attached JLABS outside America

January 19, 2017

As Johnson & Johnson announced the establishment of its eighth JLABS facility, in collaboration with New York State and the New York Genome Center, Melinda Richter, head of Johnson & Johnson Innovation, JLABS, tells Mike Ward, global director of content at Informa Pharma Intelligence’s insights portfolio, that the company is actively looking to establish JLABS in Europe and Asia with an expectation that there will be news on this front in the near future.

 


Meet Johnson & Johnson at BIO-Europe Spring® springtime partnering conference taking place in Barcelona, Spain March 20–22, 2017. Find out more.

 

Previous Article
Rare diseases, rare commitment
Rare diseases, rare commitment

Patients, their families and patient foundations are invaluable in helping drug developers understand the d...

Next Article
Thirteen young people bucking the odds, finding paths to break into biotech
Thirteen young people bucking the odds, finding paths to break into biotech

Guest post by Luke Timmerman, founder and editor of the Timmerman Report, and a regular contributor to Forb...